2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)

2016-06-30 中国医师协会内分泌代谢科医师分会 中华内分泌代谢杂志,2016,32(06):455-460.

慢性肾脏病是严重威胁人类健康的常见慢性病,病因多种多样,由糖尿病所引发的慢性肾脏病称为糖尿病肾脏病变。2型糖尿病常合并慢性肾脏病,高血糖是慢性肾脏病发生和发展的主要原因之一,因此良好控制血糖至关重要。口服降糖药是良好控制血糖最常用的降糖药物。中国医师协会内分泌代谢科医师分会于2013年组织国内的内分泌科和肾内科领域专家,共同制定了"2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识" 。近年来

中文标题:

2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)

发布日期:

2016-06-30

简要介绍:

慢性肾脏病是严重威胁人类健康的常见慢性病,病因多种多样,由糖尿病所引发的慢性肾脏病称为糖尿病肾脏病变。2型糖尿病常合并慢性肾脏病,高血糖是慢性肾脏病发生和发展的主要原因之一,因此良好控制血糖至关重要。口服降糖药是良好控制血糖最常用的降糖药物。中国医师协会内分泌代谢科医师分会于2013年组织国内的内分泌科和肾内科领域专家,共同制定了"2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识" 。近年来,2型糖尿病合并慢性肾脏病患者中口服降糖药治疗证据不断丰富,国内外糖尿病及肾脏病权威指南对2型糖尿病合并慢性肾脏病的口服降糖药应用规范也进行了相应更新,加之同时陆续有新的口服降糖药上市。因此,本分会再次组织相关专家对原有共识进行了更新完善。



相关资料下载:
[AttachmentFileName(sort=100, fileName=2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版))] GetToolGuiderByIdResponse(projectId=1, id=f8fa71c0012312d3, title=2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版), enTitle=, guiderFrom=中华内分泌代谢杂志,2016,32(06):455-460., authorId=null, author=, summary=慢性肾脏病是严重威胁人类健康的常见慢性病,病因多种多样,由糖尿病所引发的慢性肾脏病称为糖尿病肾脏病变。2型糖尿病常合并慢性肾脏病,高血糖是慢性肾脏病发生和发展的主要原因之一,因此良好控制血糖至关重要。口服降糖药是良好控制血糖最常用的降糖药物。中国医师协会内分泌代谢科医师分会于2013年组织国内的内分泌科和肾内科领域专家,共同制定了"2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识" 。近年来, cover=, journalId=null, articlesId=null, associationId=225, associationName=中国医师协会内分泌代谢科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Jun 30 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=慢性肾脏病是严重威胁人类健康的常见慢性病,病因多种多样,由糖尿病所引发的慢性肾脏病称为糖尿病肾脏病变。2型糖尿病常合并慢性肾脏病,高血糖是慢性肾脏病发生和发展的主要原因之一,因此良好控制血糖至关重要。口服降糖药是良好控制血糖最常用的降糖药物。中国医师协会内分泌代谢科医师分会于2013年组织国内的内分泌科和肾内科领域专家,共同制定了"2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识" 。近年来,2型糖尿病合并慢性肾脏病患者中口服降糖药治疗证据不断丰富,国内外糖尿病及肾脏病权威指南对2型糖尿病合并慢性肾脏病的口服降糖药应用规范也进行了相应更新,加之同时陆续有新的口服降糖药上市。因此,本分会再次组织相关专家对原有共识进行了更新完善。<div><br></div><div><br></div>, tagList=[TagDto(tagId=2052, tagName=2型糖尿病), TagDto(tagId=2527, tagName=慢性肾脏病), TagDto(tagId=3513, tagName=口服降糖药)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6050, appHits=499, showAppHits=15, pcHits=3213, showPcHits=2840, likes=200, shares=17, comments=4, approvalStatus=1, publishedTime=Thu Jul 07 16:12:07 CST 2016, publishedTimeString=2016-06-30, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Thu Jul 07 16:12:07 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 06:46:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版))])
2型糖尿病合并慢性肾脏病口服降糖药用药原则中国专家共识(2015年更新版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=972616, encodeId=b7c49e261696, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Thu Jun 10 18:03:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150580, encodeId=a5671505809f, content=谢谢!有收获!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87df1446011, createdName=waxibin, createdTime=Sun Oct 23 12:00:34 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92277, encodeId=119f922e72d, content=不错啊!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/25/ba882cb566d3be250a05e2a69b80f2c9.jpg, createdBy=32881678798, createdName=小M医师, createdTime=Thu Jul 07 17:23:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92274, encodeId=2fcd922e49b, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=medsci1024, createdTime=Thu Jul 07 17:03:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2021-06-10 1483f8cem53(暂无昵称)

    好资料!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=972616, encodeId=b7c49e261696, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Thu Jun 10 18:03:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150580, encodeId=a5671505809f, content=谢谢!有收获!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87df1446011, createdName=waxibin, createdTime=Sun Oct 23 12:00:34 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92277, encodeId=119f922e72d, content=不错啊!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/25/ba882cb566d3be250a05e2a69b80f2c9.jpg, createdBy=32881678798, createdName=小M医师, createdTime=Thu Jul 07 17:23:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92274, encodeId=2fcd922e49b, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=medsci1024, createdTime=Thu Jul 07 17:03:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-10-23 waxibin

    谢谢!有收获!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=972616, encodeId=b7c49e261696, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Thu Jun 10 18:03:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150580, encodeId=a5671505809f, content=谢谢!有收获!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87df1446011, createdName=waxibin, createdTime=Sun Oct 23 12:00:34 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92277, encodeId=119f922e72d, content=不错啊!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/25/ba882cb566d3be250a05e2a69b80f2c9.jpg, createdBy=32881678798, createdName=小M医师, createdTime=Thu Jul 07 17:23:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92274, encodeId=2fcd922e49b, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=medsci1024, createdTime=Thu Jul 07 17:03:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-07 小M医师

    不错啊!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=972616, encodeId=b7c49e261696, content=好资料!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a7975280135, createdName=1483f8cem53(暂无昵称), createdTime=Thu Jun 10 18:03:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=150580, encodeId=a5671505809f, content=谢谢!有收获!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87df1446011, createdName=waxibin, createdTime=Sun Oct 23 12:00:34 CST 2016, time=2016-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92277, encodeId=119f922e72d, content=不错啊!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=202, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/25/ba882cb566d3be250a05e2a69b80f2c9.jpg, createdBy=32881678798, createdName=小M医师, createdTime=Thu Jul 07 17:23:00 CST 2016, time=2016-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=92274, encodeId=2fcd922e49b, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c891611001, createdName=medsci1024, createdTime=Thu Jul 07 17:03:00 CST 2016, time=2016-07-07, status=1, ipAttribution=)]
    2016-07-07 medsci1024

    很实用

    0